ClinConnect ClinConnect Logo
Search / Trial NCT03153384

Impact of the Blood Culture Technique on the Diagnosis of Infective Endocarditis

Launched by CENTRAL HOSPITAL, NANCY, FRANCE · May 12, 2017

Trial Information

Current as of May 27, 2025

Completed

Keywords

Diagnosis Blood Culture

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients older than 18 years
  • Suspected endocarditis: Patients with Duke-Li-ESC 2015 classification as a major morphological criterion or at least two minor criteria, other than a microbiological criterion, will be considered suspicious of infectious endocarditis.
  • Not objecting to their inclusion in the study after delivery and explanation of the information form.
  • Absence of microbiological documentation sought or available at the time of inclusion (a patient having already had negative blood cultures or being identified during the screening can be included).
  • Exclusion Criteria:
  • Antibiotherapy adapted to a situation of endocarditis, introduced more than 24 hours or stopped for less than 7 days in case of therapeutic window.
  • Any previous antibiotic therapy in the 7 days preceding the inclusion leading to an improvement in the clinical symptomatology.
  • State of consciousness not allowing loyal information.

About Central Hospital, Nancy, France

Central Hospital, located in Nancy, France, is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes. As a prominent clinical trial sponsor, the hospital is committed to conducting innovative studies across various therapeutic areas, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. With a strong emphasis on ethical standards and patient safety, Central Hospital leverages its state-of-the-art facilities and expertise to contribute to the development of cutting-edge treatments and enhance the overall quality of care within the community and beyond.

Locations

Paris, , France

Reims, , France

Besancon, , France

Belfort, , France

Dijon, , France

Nancy, , France

Rennes, , France

Strasbourg, , France

Patients applied

0 patients applied

Trial Officials

François Goehringer, MD

Principal Investigator

Centre Hospitalier Universitaire de Nancy, Nancy, France

Xavier Duval, MD PhD

Study Chair

APHP, Hôpital Bichat Claude Bernard, Paris, France.

Christine Selton-Suty, MD

Study Chair

Centre Hospitalier Universitaire de Nancy, Nancy, France

Nejla Aissa, MD

Study Chair

Centre Hospitalier Universitaire de Nancy, Nancy, France

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials